Systemic candidiasis with candida vasculitis due to Candida kruzei in a patient with acute myeloid leukaemia

Bone Marrow Transplantation

Volumn 23, Issue 1, 1999, Pages 103-104

  Gregory, R K ^a   Powles, R L ^a   Treleaven, J G ^a,b   Smith, M L ^a   Mortimer, P S ^a   Wotherspoon, A ^a   Riley, U ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Bone marrow transplantation; Candida kruzei; Candida vasculitis; Leukaemia; Systemic candidiasis; Triazoles

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; ANTIFUNGAL AGENT; ANTINEOPLASTIC AGENT; CYTARABINE; IDARUBICIN; TRIAZOLE DERIVATIVE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; BLOOD CULTURE; CANCER CHEMOTHERAPY; CANDIDA KRUSEI; CANDIDIASIS; CASE REPORT; CLINICAL FEATURE; DRUG MEGADOSE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; PROPHYLAXIS; SKIN BIOPSY; VASCULITIS;

EID: 0033008333     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701539     Document Type: Article

References (5)

1. Anaissie E, Hachem R, Tin K et al. Experimental haematogenous candidiasis caused by Candida kruzei and Candida albicans: species differences in pathogenicity. Infect Immun 1993; 61: 1268-1271.
2. Collignon PJ, Sorrell TC et al. Disseminated candidiasis: evidence of a distinctive syndrome in heroin abusers. Br Med J 1983; 287: 861-862.
3. Bandini G, Ricci P, Guardigli C et al. Unexpected presentation of deep candidiasis in a recipient of a mismatched bone marrow transplant. Acta Haematol 1986; 75: 116-119.
4. Booth LV, Collins AL, Lowes A et al. Skin rash associated with Candida guilliermondii. Med Paediatr Oncol 1998; 16: 295-296.
5. Karyotakis NC, Anaissie EJ. Efficacy of escalating doses of liposomal amphotericin B (ambisome) against haematogenous Candida lusitaniae and Candida kruzei infection neutropenic mice. Antimicrob Agents Chemother 1994; 38: 2660-2662.